oxonic acid has been researched along with Adenocarcinoma, Scirrhous in 25 studies
Oxonic Acid: Antagonist of urate oxidase.
Adenocarcinoma, Scirrhous: An adenocarcinoma with a hard (Greek skirrhos, hard) structure owing to the formation of dense connective tissue in the stroma. (From Dorland, 27th ed)
| Excerpt | Relevance | Reference |
|---|---|---|
| "We diagnosed her case to be bilateral breast cancer with peritonitis carcinomatosa, lymph node metastases and bony metastases." | 5.35 | [A case of bilateral breast cancer and metastatic gastric cancer with peritonitis carcinomatosa successfully treated with a combination therapy of S-1 and paclitaxel]. ( Aramaki, N; Iizuka, M; Kuranami, M; Kurita, A; Miyauchi, K; Nakakuma, T; Sengoku, N; Shiozawa, K; Ueno, S, 2009) |
| "The prognosis of scirrhous gastric cancer remains poor despite extended surgery or adjuvant or neoadjuvant chemotherapy." | 2.74 | Phase II trial of S-1 for neoadjuvant chemotherapy against scirrhous gastric cancer (JCOG 0002). ( Furukawa, H; Kaji, M; Katai, H; Kinoshita, T; Miyashiro, I; Ninomiya, M; Sano, T; Sasako, M; Tsuburaya, A, 2009) |
| "A 35-year-old female with scirrhous stomach cancer (stage IV) was treated with a combination of 5-aminolevulinic acid (ALA), sodium dichloroacetate (DCA), hyperthermotherapy, and immunotherapy as terminal care." | 1.39 | A patient with scirrhous stomach cancer treated with combination of hyperthermotherapy and 5-aminolevulinic acid (ALA). ( Goto, S; Kamigaki, T; Saito, M; Yano, K, 2013) |
| "Scirrhous type of gastric cancer was suspected and gastric forceps biopsy was performed at many points under the retreated endoscopic examinations." | 1.37 | [A case report of scirrhous gastric carcinoma diagnosed by staging laparoscopy]. ( Fukunaga, M; Furukawa, H; Imamura, H; Kawabata, R; Kishimoto, T; Munakata, S; Ohzato, H; Takemoto, H; Yamamoto, T, 2011) |
| "We diagnosed her case to be bilateral breast cancer with peritonitis carcinomatosa, lymph node metastases and bony metastases." | 1.35 | [A case of bilateral breast cancer and metastatic gastric cancer with peritonitis carcinomatosa successfully treated with a combination therapy of S-1 and paclitaxel]. ( Aramaki, N; Iizuka, M; Kuranami, M; Kurita, A; Miyauchi, K; Nakakuma, T; Sengoku, N; Shiozawa, K; Ueno, S, 2009) |
| "Paclitaxel also has a high response rate for undifferentiated-type adenocarcinoma, and can be expected to show high efficacy for peritoneal dissemination." | 1.34 | [Therapeutic strategy for type 4 gastric cancer from the clinical oncologist standpoint]. ( Ae, T; Higuchi, K; Ishido, K; Katada, C; Koizumi, W; Nakatani, K; Saigenji, K; Sasaki, T; Tanabe, S, 2007) |
| "Case 1: 66-year-old male with advanced gastric cancer invading the pancreas with metastasis to the liver and left neck lymph nodes." | 1.33 | [Three advanced gastric cancer patients successfully treated by combination therapy of docetaxel and TS-1]. ( Hamai, Y; Hihara, J; Ohta, K; Suzuki, T; Tanabe, K; Taomoto, J; Toge, T; Yoshida, K, 2005) |
| "One case with type 4 gastric cancer who had right hydronephrosis and malignant abdominal ascites underwent curative resection after successful treatment with TS-1." | 1.33 | [Peritoneal dissemination of scirrhous type 4 gastric cancers]. ( Aoyagi, K; Imaizumi, T; Koufuji, K; Miyagi, M; Murakami, N; Shirouzu, K; Yano, S, 2005) |
| "Since metastases to the liver, left adrenal gland, and Douglas' pouch were detected in addition to ascites and bilateral hydronephrosis, the tumor was judged unresectable and systemic chemotherapy with TS-1 was begun." | 1.31 | [A case in which TS-1, an orally-administered 5-FU chemotherapeutic agent, showed marked effectiveness against scirrhous type gastric cancer with multiple organ metastases]. ( Araki, S; Asakura, R; Itou, A; Kobayashi, K; Naganuma, J; Teruya, M; Yanagida, O, 2002) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 18 (72.00) | 29.6817 |
| 2010's | 7 (28.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Saito, M | 1 |
| Yano, K | 1 |
| Kamigaki, T | 1 |
| Goto, S | 1 |
| Kunisaki, C | 1 |
| Makino, H | 1 |
| Kimura, J | 1 |
| Takagawa, R | 1 |
| Kanazawa, A | 1 |
| Ota, M | 1 |
| Kosaka, T | 1 |
| Ono, HA | 1 |
| Akiyama, H | 1 |
| Endo, I | 1 |
| Tanabe, D | 1 |
| Kondou, K | 1 |
| Uchiyama, T | 1 |
| Noda, K | 1 |
| Kinoshita, T | 2 |
| Sasako, M | 1 |
| Sano, T | 1 |
| Katai, H | 1 |
| Furukawa, H | 3 |
| Tsuburaya, A | 1 |
| Miyashiro, I | 1 |
| Kaji, M | 1 |
| Ninomiya, M | 1 |
| Ikeguchi, M | 1 |
| Kuroda, H | 1 |
| Matsunaga, T | 1 |
| Fukuda, K | 1 |
| Saito, H | 1 |
| Tatebe, S | 1 |
| Kishimoto, T | 2 |
| Imamura, H | 2 |
| Kawabata, R | 2 |
| Fukunaga, M | 2 |
| Ohzato, H | 2 |
| Ueno, S | 1 |
| Nakakuma, T | 1 |
| Aramaki, N | 1 |
| Shiozawa, K | 1 |
| Iizuka, M | 1 |
| Kurita, A | 1 |
| Miyauchi, K | 1 |
| Sengoku, N | 1 |
| Kuranami, M | 1 |
| Okita, A | 1 |
| Miyade, Y | 1 |
| Okano, K | 1 |
| Akagi, T | 1 |
| Etoh, T | 1 |
| Eguchi, H | 1 |
| Hiroishi, K | 1 |
| Ueda, Y | 1 |
| Yasuda, K | 1 |
| Noguchi, T | 1 |
| Shiraishi, N | 1 |
| Kitano, S | 1 |
| Nakamura, M | 3 |
| Kubo, N | 1 |
| Morimoto, J | 1 |
| Tanaka, H | 1 |
| Muguruma, K | 1 |
| Amano, R | 1 |
| Noda, E | 1 |
| Inoue, T | 1 |
| Takashima, T | 1 |
| Yamada, N | 2 |
| Yashiro, M | 2 |
| Yamashita, Y | 1 |
| Maeda, K | 1 |
| Onoda, N | 1 |
| Sawada, T | 2 |
| Nakata, B | 1 |
| Ohira, M | 2 |
| Ishikawa, T | 1 |
| Hirakawa, K | 2 |
| Sasaki, H | 1 |
| Idani, F | 1 |
| Asami, S | 1 |
| Komoto, S | 1 |
| Kubota, T | 1 |
| Kumano, K | 1 |
| Kurose, Y | 1 |
| Kubo, S | 1 |
| Nojima, H | 1 |
| Yoshioka, T | 1 |
| Muro, M | 1 |
| Kin, H | 1 |
| Takakura, N | 1 |
| Munakata, S | 1 |
| Yamamoto, T | 1 |
| Takemoto, H | 1 |
| Iwase, H | 2 |
| Mizuno, T | 2 |
| Iyo, T | 2 |
| Nakarai, K | 2 |
| Kaida, S | 2 |
| Indo, T | 2 |
| Hiraiwa, A | 1 |
| Shimada, M | 1 |
| Okeya, M | 1 |
| Kusugami, K | 1 |
| Ina, K | 1 |
| Tanino, M | 1 |
| Mizuno, C | 1 |
| Shiomi, T | 1 |
| Shima, T | 1 |
| Nakajo, S | 1 |
| Hara, A | 2 |
| Hashimoto, K | 1 |
| Konishi, M | 1 |
| Nakagohri, T | 1 |
| Inoue, K | 2 |
| Oda, T | 1 |
| Takahashi, S | 1 |
| Boku, N | 1 |
| Ohtsu, A | 1 |
| Yoshida, S | 1 |
| Takahashi, Y | 1 |
| Tokuhara, T | 1 |
| Izumi, N | 2 |
| Iwamoto, S | 1 |
| Satake, K | 1 |
| Itakura, J | 1 |
| Nishimura, M | 1 |
| Ueda, K | 1 |
| Tsuchiya, K | 1 |
| Hamano, K | 1 |
| Asahina, Y | 1 |
| Noguchi, O | 1 |
| Uchihara, M | 1 |
| Miyake, S | 1 |
| Suzuki, T | 1 |
| Yoshida, K | 1 |
| Tanabe, K | 1 |
| Hihara, J | 1 |
| Ohta, K | 1 |
| Hamai, Y | 1 |
| Taomoto, J | 1 |
| Toge, T | 1 |
| Koufuji, K | 1 |
| Aoyagi, K | 1 |
| Yano, S | 1 |
| Murakami, N | 1 |
| Miyagi, M | 1 |
| Imaizumi, T | 1 |
| Shirouzu, K | 1 |
| Tendo, M | 1 |
| Nakazawa, K | 1 |
| Kameyama, S | 1 |
| Murayama, R | 1 |
| Miyazato, K | 1 |
| Kurashita, K | 1 |
| Ishimine, T | 1 |
| Nagamine, Y | 1 |
| Kohakura, F | 1 |
| Shinzato, S | 1 |
| Tomimori, K | 1 |
| Kugai, Y | 1 |
| Uchima, H | 1 |
| Sasaki, T | 1 |
| Koizumi, W | 1 |
| Higuchi, K | 1 |
| Ishido, K | 1 |
| Ae, T | 1 |
| Nakatani, K | 1 |
| Katada, C | 1 |
| Tanabe, S | 1 |
| Saigenji, K | 1 |
| Doi, S | 1 |
| Yanagisawa, T | 1 |
| Makari, Y | 1 |
| Tanaka, N | 1 |
| Naoi, M | 1 |
| Maruyama, H | 1 |
| Yanagida, O | 1 |
| Teruya, M | 1 |
| Kobayashi, K | 1 |
| Itou, A | 1 |
| Naganuma, J | 1 |
| Asakura, R | 1 |
| Araki, S | 1 |
1 review available for oxonic acid and Adenocarcinoma, Scirrhous
| Article | Year |
|---|---|
[A case of scirrhous gastric carcinoma with peritoneal dissemination which was treated by curative gastrectomy after S-1/CDDP chemotherapy].
Topics: Adenocarcinoma, Scirrhous; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Combinati | 2010 |
1 trial available for oxonic acid and Adenocarcinoma, Scirrhous
| Article | Year |
|---|---|
Phase II trial of S-1 for neoadjuvant chemotherapy against scirrhous gastric cancer (JCOG 0002).
Topics: Adenocarcinoma, Scirrhous; Adult; Aged; Antimetabolites, Antineoplastic; Chemotherapy, Adjuvant; Com | 2009 |
23 other studies available for oxonic acid and Adenocarcinoma, Scirrhous
| Article | Year |
|---|---|
A patient with scirrhous stomach cancer treated with combination of hyperthermotherapy and 5-aminolevulinic acid (ALA).
Topics: Adenocarcinoma, Scirrhous; Adult; Aminolevulinic Acid; Antineoplastic Combined Chemotherapy Protocol | 2013 |
Impact of S-1 plus Cisplatin Neoadjuvant Chemotherapy on Scirrhous Gastric Cancer.
Topics: Adenocarcinoma, Scirrhous; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy | 2015 |
[A case of scirrhous gastric cancer with peritoneal dissemination acquiring stable disease over three years by treatment with oral anticancer drug S-1].
Topics: Adenocarcinoma, Scirrhous; Administration, Oral; Aged; Antineoplastic Combined Chemotherapy Protocol | 2008 |
[Intra-peritoneal chemotherapy for scirrhous gastric cancer].
Topics: Adenocarcinoma, Scirrhous; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Co | 2009 |
[Three scirrhous gastric cancer cases with CY negativity in second-look staging laparoscopy after chemotherapy to whom curative surgery was carried out].
Topics: Adenocarcinoma, Scirrhous; Adult; Aged; Antimetabolites, Antineoplastic; Antineoplastic Agents; Anti | 2009 |
[A case of bilateral breast cancer and metastatic gastric cancer with peritonitis carcinomatosa successfully treated with a combination therapy of S-1 and paclitaxel].
Topics: Adenocarcinoma, Scirrhous; Antimetabolites, Antineoplastic; Antineoplastic Agents, Phytogenic; Antin | 2009 |
Effective management of an advanced gastric cancer patient by TS-1 combined chemotherapy using nasojejunal tube and successful transfer to home care after percutaneous transesophageal gastro-tubing (PTEG): a case report.
Topics: Adenocarcinoma, Scirrhous; Aged; Antimetabolites, Antineoplastic; Antineoplastic Agents, Phytogenic; | 2010 |
[A case of type 4 gastric cancer with positive peritoneal lavage cytology, which relapsed at the peritoneum at the time of seven years and eight months after resection].
Topics: Adenocarcinoma, Scirrhous; Antimetabolites, Antineoplastic; Drug Combinations; Female; Gastrectomy; | 2010 |
[A long-term survival case of bilateral ovarian metastasis of progressive gastric cancer treated by chemotherapy].
Topics: Adenocarcinoma, Scirrhous; Aged; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplas | 2010 |
[A case report of scirrhous gastric carcinoma diagnosed by staging laparoscopy].
Topics: Adenocarcinoma, Scirrhous; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Cisplatin; Drug C | 2011 |
[Complete response in an elderly patient with advanced gastric scirrhous cancer treated with combined chemotherapy of TS-1 and CDDP].
Topics: Adenocarcinoma, Scirrhous; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Adm | 2002 |
[Complete response in a case of advanced scirrhous type 3 gastric cancer of with bulky N2 para-aorta lymph node metastases treated by combined chemotherapy of TS-1 and CDDP].
Topics: Adenocarcinoma, Scirrhous; Antineoplastic Combined Chemotherapy Protocols; Aorta; Cisplatin; Drug Ad | 2002 |
[A case of stomach cancer in which TS-1 neoadjuvant therapy was effective against multiple hepatic metastasis, allowing a radical cure A surgery].
Topics: Adenocarcinoma, Scirrhous; Antimetabolites, Antineoplastic; Drug Administration Schedule; Drug Combi | 2002 |
Neoadjuvant chemotherapy with S-1 for scirrhous gastric cancer: a pilot study.
Topics: Adenocarcinoma, Scirrhous; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Pro | 2003 |
[A case of inoperable scirrhous gastric cancer that responded remarkably to a combination of TS-1+paclitaxel and showed complete loss of ascites].
Topics: Adenocarcinoma, Scirrhous; Antineoplastic Combined Chemotherapy Protocols; Ascitic Fluid; Drug Admin | 2004 |
[A case of advanced gastric cancer acquired long-term response two years or more by treatment with oral anticancer drug TS-1].
Topics: Adenocarcinoma, Scirrhous; Aged; Antimetabolites, Antineoplastic; Drug Combinations; Humans; Male; O | 2004 |
[Three advanced gastric cancer patients successfully treated by combination therapy of docetaxel and TS-1].
Topics: Adenocarcinoma, Scirrhous; Aged; Antineoplastic Combined Chemotherapy Protocols; Docetaxel; Drug Adm | 2005 |
[Peritoneal dissemination of scirrhous type 4 gastric cancers].
Topics: Adenocarcinoma, Scirrhous; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; C | 2005 |
A synergic inhibitory-effect of combination with selective cyclooxygenase-2 inhibitor and S-1 on the peritoneal metastasis for scirrhous gastric cancer cells.
Topics: Adenocarcinoma, Scirrhous; Animals; Antimetabolites, Antineoplastic; Benzenesulfonates; Cyclooxygena | 2006 |
[A case of scirrhous gastric cancer responding to TS-1/CDDP neoadjuvant chemotherapy].
Topics: Adenocarcinoma, Scirrhous; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Adm | 2006 |
[Therapeutic strategy for type 4 gastric cancer from the clinical oncologist standpoint].
Topics: Adenocarcinoma, Scirrhous; Adult; Aged; Antimetabolites, Antineoplastic; Antineoplastic Agents, Phyt | 2007 |
[A case of hepatic metastasis of gastric cancer responding to TS-1, administered for two consecutive weeks and one week rest].
Topics: Adenocarcinoma, Scirrhous; Aged; Antimetabolites, Antineoplastic; Drug Administration Schedule; Drug | 2001 |
[A case in which TS-1, an orally-administered 5-FU chemotherapeutic agent, showed marked effectiveness against scirrhous type gastric cancer with multiple organ metastases].
Topics: Adenocarcinoma, Scirrhous; Administration, Oral; Aged; Antineoplastic Combined Chemotherapy Protocol | 2002 |